Status:

TERMINATED

Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery

Lead Sponsor:

Institut Cancerologie de l'Ouest

Collaborating Sponsors:

National Cancer Institute, France

Conditions:

Breast Cancer

Gynecologic Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This trial offers support and assistance to patients wishing to quit smoking in order to increase the success rate of smoking cessation and all the benefits associated with it. Patients will be monito...

Detailed Description

The study RESPIRE is aiming to identify some interventions to be proposed as part of a smoking cessation programme for smokers with cancer requiring surgical treatment and wishing to stop smoking. We ...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years.
  • Smoking patient: daily tobacco consumption.
  • Patient with cancer requiring surgical treatment (breast cancer, digestive cancer, gynecological).
  • Patient wishing to quit smoking.
  • Fagerström \> 3.
  • Patient has valid health insurance
  • Information and agreement of the patient to participate in the longitudinal cohort.
  • Signing of specific informed consent for patients in groups 1 to 4 before any study-related intervention.
  • Person able to speak, read and understand French.

Exclusion

  • Patient not receiving surgical treatment.
  • Refusal to participate in the longitudinal cohort study.
  • Pregnant or likely to be pregnant or nursing patient.
  • Persons deprived of their liberty, under a measure of safeguard of justice, under guardianship or placed under the authority of a guardian
  • disability to undergo the medical follow-up of the trial for geographical, social or psychological reasons.

Key Trial Info

Start Date :

September 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 29 2024

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT04899492

Start Date

September 29 2021

End Date

March 29 2024

Last Update

November 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut de Cancerologie de l'Ouest (ICO)

Saint-Herblain, France, 44805